To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene OTUD5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
435 supporting clones for gene OTUD5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001136157.1   .a 1 to 2908 1 to 2908 exact RefSeq, AAA   2908/2908
(100 %)
0 diff
(100 %id)
AL137509 amygdala .a 479 to 2725 1 to 2247   tiling clone, available from DKFZ, AAA   2247/2247
(100 %)
1 diff
(100.0 %id)
AK026260 human small intestine .a 587 to 2298 1 to 1712   available from FLJ, AAA   1712/1712
(100 %)
0 diff
(100 %id)
DA063514 cerebellum .b 1 to 400 2 to 402   capped   401/401
(100 %)
1 diff
(99.8 %id)
DA237046 brain .b 1 to 413 2 to 414   tiling clone, capped   413/413
(100 %)
0 diff
(100 %id)
CN295275 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 21 to 440 1 to 420       420/420
(100 %)
7 diff
(98.4 %id)
BQ716299 sympathetic trunk .b 35 to 388 1 to 354       354/980
(36 %)
1 diff
(99.9 %id)
BM797460 stomach .b 44 to 546 1 to 503       503/503
(100 %)
3 diff
(99.5 %id)
DA358154 subthalamic nucleus .b 48 to 345 2 to 299   capped   298/298
(100 %)
0 diff
(100 %id)
CN295277 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 51 to 354 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AI650316 Kidney .b 86 to 542 457 to 1   tiling clone,   457/457
(100 %)
0 diff
(100 %id)
CN295276 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 96 to 328 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
BY799160 eye .b 461 to 1002 1 to 542       542/542
(100 %)
0 diff
(100 %id)
CB989931 Human Placenta, placenta .b 481 to 1232 27 to 783       757/785
(96 %)
12 diff
(98.5 %id)
CX163973 human embryonic stem cells differentiated toan early endodermal cell type .b 488 to 1203 1 to 716   tiling clone,   716/716
(100 %)
0 diff
(100 %id)
CN266180 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 505 to 834 19 to 347       329/347
(94 %)
6 diff
(98.3 %id)
CT002746 T-Lymphocytes .b 506 to 657 1 to 154       154/165
(93 %)
3 diff
(98.2 %id)
DN999758   .b 647 to 1192 1 to 546       546/546
(100 %)
6 diff
(99.0 %id)
BQ687057 ductal carcinoma, cell line, Pancreas .b 746 to 1169 1 to 424       424/975
(43 %)
7 diff
(99.3 %id)
BC009917 Kidney, renal cell adenocarcinoma .b 750 to 3489 1 to 2740 exact tiling clone, available from MGC, AAA   2740/2740
(100 %)
0 diff
(100 %id)
NM_017602.3   .b 750 to 3672 1 to 2923 exact RefSeq, AAA   2923/2923
(100 %)
0 diff
(100 %id)
DR006794 Spleen .b 762 to 1201 1 to 440       440/445
(98 %)
6 diff
(98.7 %id)
CR983029 T-Lymphocytes .b 771 to 1132 1 to 362       362/367
(98 %)
1 diff
(99.8 %id)
BM763011 myeloma .b 781 to 893 1 to 114       114/114
(100 %)
6 diff
(94.8 %id)
BU500455   .b 797 to 1210 11 to 424       414/1073
(38 %)
1 diff
(100.0 %id)
BQ647562 hepatocellular carcinoma, cell line, Liver .b 817 to 1195 1 to 379       379/1125
(33 %)
6 diff
(99.5 %id)
BQ651859 hepatocellular carcinoma, cell line, Liver .b 817 to 1186 1 to 370       370/1057
(35 %)
6 diff
(99.5 %id)
CX761260 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1208 to 1922 1 to 714     Submitted on the opposite strand 714/715
(99 %)
2 diff
(99.8 %id)
CB266956 adipose .b 1302 to 1879 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BG763157 melanotic melanoma, high MDR (cell line), skin .b 1362 to 2075 1 to 715       715/715
(100 %)
5 diff
(99.4 %id)
BG763344 melanotic melanoma, high MDR (cell line), skin .b 1362 to 2188 1 to 823       823/823
(100 %)
7 diff
(99.2 %id)
BG328776 adenocarcinoma cell line, colon .b 1398 to 2203 1 to 798       798/800
(99 %)
24 diff
(97.0 %id)
BI260660 cervical carcinoma cell line, cervix .b 1530 to 2292 1 to 763       763/866
(88 %)
7 diff
(99.2 %id)
AK022612   .b 1567 to 3489 1 to 1923   available from FLJ,   1923/1923
(100 %)
2 diff
(99.9 %id)
AU124888   .b 1568 to 2292 2 to 727   capped   726/726
(100 %)
5 diff
(99.4 %id)
BQ933575 large cell carcinoma, lung .b 1616 to 2555 1 to 942       942/942
(100 %)
11 diff
(98.9 %id)
AU148666   .b 2936 to 3489 555 to 1       555/557
(99 %)
15 diff
(97.4 %id)
DB297153 cerebellum .b 3164 to 3487 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
NM_001136158.1   .c 1 to 2682 1 to 2682 exact RefSeq, AAA   2682/2682
(100 %)
0 diff
(100 %id)
AW732279 Kidney, renal cell adenocarcinoma .c 2 to 392 1 to 391   tiling clone,   391/391
(100 %)
1 diff
(99.8 %id)
AL555259 placenta .c 11 to 753 1 to 742       742/742
(100 %)
12 diff
(98.4 %id)
BX376889 Neuroblastoma Cot 50-normalized .c 23 to 753 1 to 729       729/729
(100 %)
23 diff
(96.9 %id)
CX751817 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 23 to 753 1 to 731     Submitted on the opposite strand 731/814
(89 %)
7 diff
(99.2 %id)
BM846786 myeloma .c 32 to 500 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
BQ646458 hepatocellular carcinoma, cell line, Liver .c 47 to 610 1 to 569       569/1046
(54 %)
19 diff
(98.2 %id)
AI751484 Bone, Hip .c 74 to 552 1 to 480       480/480
(100 %)
6 diff
(98.8 %id)
BQ220244 large cell carcinoma, lung .c 79 to 647 1 to 572       572/949
(60 %)
15 diff
(98.5 %id)
BM449448 eye, retinoblastoma .c 93 to 570 1 to 478   AAA   478/1162
(41 %)
16 diff
(98.7 %id)
BI833728 pooled pancreas and spleen .c 123 to 702 36 to 638       601/731
(82 %)
14 diff
(98.1 %id)
TI_57166815   .c 123 to 782 63 to 756       645/758
(85 %)
26 diff
(96.6 %id)
CN368443 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 199 to 539 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
BG898463 cartilage .c 202 to 650 56 to 505       450/459
(98 %)
7 diff
(98.5 %id)
BG473479 eye, retinoblastoma .c 202 to 814 1 to 637       605/895
(67 %)
39 diff
(95.7 %id)
BE616599 adenocarcinoma, Pancreas .c 203 to 956 38 to 801       764/804
(95 %)
15 diff
(98.2 %id)
BG761564 melanotic melanoma, high MDR (cell line), skin .c 260 to 878 1 to 618   tiling clone,   618/618
(100 %)
2 diff
(99.7 %id)
BI257310 cervical carcinoma cell line, cervix .c 267 to 875 12 to 649       638/834
(76 %)
24 diff
(97.2 %id)
BF794794 lymph, lymphoma, cell line .c 380 to 975 72 to 681       610/910
(67 %)
31 diff
(96.6 %id)
BX390952   .c 386 to 1053 87 to 753       667/845
(78 %)
22 diff
(97.4 %id)
DA716605   .c 408 to 968 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BG324802 Kidney, renal cell adenocarcinoma .c 422 to 1120 1 to 700       700/815
(85 %)
11 diff
(98.7 %id)
BM012894 brain, neuroblastoma, cell line .c 443 to 1090 4 to 642       639/642
(99 %)
23 diff
(96.5 %id)
TI_59382125   .c 443 to 1090 102 to 740       639/641
(99 %)
23 diff
(96.5 %id)
BF974493 B-cells, primary B-cells from tonsils (cell line) .c 444 to 1122 1 to 686   available from MGC,   686/929
(73 %)
15 diff
(98.4 %id)
BG755958 B-cells, primary B-cells from tonsils (cell line) .c 444 to 1271 1 to 832       832/832
(100 %)
8 diff
(99.1 %id)
BI117665 lung, small cell carcinoma .c 444 to 1178 1 to 737       737/738
(99 %)
19 diff
(97.5 %id)
BC011738 Primary B-Cells from Tonsils .c 445 to 2503 1 to 2059   tiling clone, available from MGC, AAA   2059/2059
(100 %)
1 diff
(100.0 %id)
BQ073317 epidermoid carcinoma, cell line, lung .c 448 to 1323 1 to 888       888/1012
(87 %)
27 diff
(97.4 %id)
TI_57234334   .c 454 to 1117 28 to 691       664/691
(96 %)
7 diff
(99.0 %id)
BI907602 leukocyte .c 458 to 1117 1 to 660       660/660
(100 %)
3 diff
(99.6 %id)
DA711326   .c 471 to 1029 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BG397470 B-cells, primary B-cells from tonsils (cell line) .c 478 to 1319 1 to 843       843/843
(100 %)
8 diff
(99.1 %id)
BG759240 B-cells, primary B-cells from tonsils (cell line) .c 478 to 1293 1 to 819       819/820
(99 %)
10 diff
(98.8 %id)
BU859558 ovary, teratocarcinoma, cell line .c 486 to 1120 1 to 645       645/949
(67 %)
32 diff
(96.7 %id)
BX350659   .c 499 to 1404 903 to 1       903/907
(99 %)
19 diff
(98.0 %id)
BQ931760 epidermoid carcinoma, cell line, lung .c 505 to 1237 1 to 736       736/914
(80 %)
12 diff
(98.7 %id)
BQ668806 epidermoid carcinoma, cell line, salivary gland .c 561 to 1472 1 to 916       916/916
(100 %)
27 diff
(97.1 %id)
BQ674755 epidermoid carcinoma, cell line, salivary gland .c 577 to 1447 1 to 876       876/887
(98 %)
18 diff
(98.0 %id)
BQ880813 epidermoid carcinoma, cell line, salivary gland .c 577 to 1453 1 to 880       880/881
(99 %)
7 diff
(99.3 %id)
BQ672561 epidermoid carcinoma, cell line, salivary gland .c 577 to 1528 1 to 959       959/997
(96 %)
31 diff
(96.9 %id)
BQ670861 epidermoid carcinoma, cell line, salivary gland .c 577 to 1527 1 to 951       951/985
(96 %)
18 diff
(98.2 %id)
BQ668895 epidermoid carcinoma, cell line, salivary gland .c 577 to 1408 1 to 849       849/965
(87 %)
21 diff
(97.9 %id)
BQ673085 epidermoid carcinoma, cell line, salivary gland .c 577 to 1377 1 to 812       808/991
(81 %)
21 diff
(97.9 %id)
BQ672275 epidermoid carcinoma, cell line, salivary gland .c 577 to 1381 1 to 805       805/938
(85 %)
15 diff
(98.5 %id)
BQ675179 epidermoid carcinoma, cell line, salivary gland .c 577 to 1511 1 to 963       963/966
(99 %)
20 diff
(98.0 %id)
BQ671582 epidermoid carcinoma, cell line, salivary gland .c 577 to 1486 1 to 927       927/948
(97 %)
31 diff
(96.8 %id)
BQ672509 epidermoid carcinoma, cell line, salivary gland .c 577 to 1383 1 to 814       814/876
(92 %)
14 diff
(98.5 %id)
BG912282 anaplastic oligodendroglioma with 1p/19qloss, brain .c 601 to 1218 10 to 625       616/625
(98 %)
7 diff
(98.9 %id)
AA045960 colon, tumor .c 877 to 1246 1 to 369       369/369
(100 %)
4 diff
(99.0 %id)
BG741141 skin .c 1126 to 1953 1 to 828       828/828
(100 %)
7 diff
(99.2 %id)
AL577801 placenta .c 1180 to 2057 881 to 1       881/881
(100 %)
8 diff
(99.1 %id)
R50434 breast .c 1199 to 1510 1 to 312       312/312
(100 %)
9 diff
(97.2 %id)
BQ002658 Chondrosarcoma, Left Pelvis .c 1282 to 2082 816 to 19   AAA   798/804
(99 %)
7 diff
(99.2 %id)
BM794463 Ascites, stomach .c 1288 to 1897 1 to 610       610/610
(100 %)
6 diff
(99.1 %id)
TI_154100730   .c 1314 to 2070 833 to 81   AAA   753/794
(94 %)
17 diff
(97.9 %id)
CA441525 Fibrosarcoma .c 1519 to 2070 570 to 19   AAA   552/553
(99 %)
4 diff
(99.3 %id)
AA552415 colon, tumor .c 1607 to 2092 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AW295775   .c 1659 to 2072 429 to 16   AAA   414/414
(100 %)
3 diff
(99.3 %id)
DB507627 testis .c 1722 to 2093 1 to 387     Submitted on the opposite strand 387/387
(100 %)
14 diff
(96.4 %id)
AA768028 germinal center B cell .c 1757 to 2093 349 to 13   AAA   337/337
(100 %)
0 diff
(100 %id)
AA588782 colon, colon tumor .c 1758 to 2070 313 to 1       313/313
(100 %)
2 diff
(99.4 %id)
R50435 breast .c 1761 to 2070 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
AA045961 colon, tumor .c 1762 to 2071 311 to 1       311/311
(100 %)
4 diff
(98.8 %id)
AW733082 Kidney, renal cell adenocarcinoma .c 2176 to 2499 328 to 5   tiling clone,   324/328
(98 %)
0 diff
(100 %id)
CR981637 T-Lymphocytes .d 1 to 664 1 to 664   tiling clone,   664/669
(99 %)
1 diff
(99.9 %id)
DA942382 Spleen .d 266 to 851 2 to 587   tiling clone, capped   586/587
(99 %)
3 diff
(99.5 %id)
CB052088 leiomyosarcoma, soft tissue .d 753 to 1424 10 to 681   tiling clone, fully sequenced,   672/681
(98 %)
8 diff
(98.9 %id)
CN368446 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 870 to 1436 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
BM044902 carcinoma, cell line, Prostate .d 887 to 1739 1 to 852   tiling clone,   852/856
(99 %)
11 diff
(98.8 %id)
CN368455 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1074 to 1426 1 to 353       353/353
(100 %)
4 diff
(98.9 %id)
CB052087 leiomyosarcoma, soft tissue .d 1364 to 1835 501 to 30   tiling clone, fully sequenced, AAA   472/472
(100 %)
0 diff
(100 %id)
NM_001136159.1   .e 1 to 2408 1 to 2408 exact RefSeq, AAA   2408/2408
(100 %)
0 diff
(100 %id)
DC419901 uterus .e 1 to 470 1 to 472   tiling clone,   472/472
(100 %)
2 diff
(99.6 %id)
DC313391 amygdala .e 6 to 575 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC314283 amygdala .e 6 to 566 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DB209134 trachea .e 10 to 486 2 to 481   capped   480/480
(100 %)
3 diff
(99.4 %id)
CN368448 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 14 to 727 1 to 714       714/714
(100 %)
0 diff
(100 %id)
DC419796 uterus .e 34 to 588 1 to 555       555/555
(100 %)
0 diff
(100 %id)
AK294590 brain .e 49 to 1493 1 to 1445 exact tiling clone,   1445/1445
(100 %)
0 diff
(100 %id)
DC318950 brain .e 49 to 629 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC389122 Spleen .e 49 to 618 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DC389193 Spleen .e 49 to 626 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BE514718 adenocarcinoma cell line, ovary .e 61 to 750 1 to 680       680/781
(87 %)
20 diff
(97.5 %id)
CN368453 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 117 to 506 1 to 390       390/390
(100 %)
3 diff
(99.3 %id)
BE906996 epithelioid carcinoma, Pancreas .e 168 to 849 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
BG818292 anaplastic oligodendroglioma with 1p/19qloss, brain .e 173 to 1028 1 to 851       851/872
(97 %)
12 diff
(98.7 %id)
DB178506 kidney, tumor tissue .e 194 to 757 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BQ952679 large cell carcinoma, lung .e 200 to 823 1 to 626       626/852
(73 %)
14 diff
(98.4 %id)
CB045772 colon, juvenile granulosa tumor .e 218 to 616 12 to 410       399/410
(97 %)
6 diff
(98.6 %id)
BG753856 eye, normal pigmented retinal epithelium .e 218 to 1023 1 to 802       802/806
(99 %)
26 diff
(96.8 %id)
AW945699 lung_normal .e 272 to 651 382 to 2     Submitted on the opposite strand 381/679
(56 %)
0 diff
(100 %id)
AW387448 stomach .e 275 to 471 198 to 1       198/198
(100 %)
1 diff
(99.5 %id)
BG751222 eye, normal pigmented retinal epithelium .e 289 to 975 1 to 686       686/687
(99 %)
3 diff
(99.6 %id)
BI255063 cervical carcinoma cell line, cervix .e 305 to 1169 1 to 862       864/862
(100 %)
11 diff
(98.8 %id)
BG178829 adenocarcinoma, cell line, Prostate .e 310 to 1023 1 to 709       709/974
(72 %)
11 diff
(98.9 %id)
BG576902 breast, mammary adenocarcinoma, cell line .e 332 to 1169 1 to 841       840/842
(99 %)
13 diff
(98.5 %id)
DA070946 cerebellum .e 341 to 911 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA018733   .e 356 to 922 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BQ377785 uterus .e 356 to 471 121 to 9       113/121
(93 %)
0 diff
(100 %id)
DA540780 lung .e 359 to 870 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
BI048654 testis_normal .e 363 to 597 1 to 234       234/234
(100 %)
6 diff
(97.5 %id)
BG469438 adenocarcinoma cell line, colon .e 364 to 1247 1 to 888       885/893
(99 %)
30 diff
(96.7 %id)
BQ962878 leiomyosarcoma, uterus .e 366 to 1179 1 to 821       818/879
(93 %)
8 diff
(99.1 %id)
BE618056 eye, retinoblastoma .e 394 to 1142 1 to 745       745/943
(79 %)
14 diff
(98.6 %id)
AJ973489 foetal stomach .e 400 to 579 179 to 1     Submitted on the opposite strand 179/179
(100 %)
1 diff
(99.5 %id)
AJ973490 foetal stomach .e 400 to 579 1 to 179       179/179
(100 %)
1 diff
(99.5 %id)
CX755730 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 403 to 1156 1 to 750     Submitted on the opposite strand 752/753
(99 %)
8 diff
(99.0 %id)
DA606269   .e 408 to 949 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA056574 cerebellum .e 409 to 975 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA207982 brain .e 409 to 973 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA425149 colon .e 409 to 876 2 to 469   capped   468/468
(100 %)
1 diff
(99.8 %id)
DA910409   .e 410 to 960 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA598278   .e 411 to 968 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA679777   .e 412 to 975 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA948225 Spleen .e 419 to 989 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BF982351 duodenal adenocarcinoma, cell line, small intestine .e 421 to 1143 1 to 710       710/969
(73 %)
15 diff
(98.5 %id)
R18955 whole brain .e 425 to 801 1 to 378       378/378
(100 %)
6 diff
(98.5 %id)
DA273560 caudate nucleus .e 432 to 983 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BF204236 muscle, rhabdomyosarcoma .e 436 to 1142 1 to 710       710/945
(75 %)
17 diff
(98.3 %id)
BF305541 muscle, rhabdomyosarcoma .e 437 to 1142 1 to 696       698/950
(73 %)
25 diff
(97.4 %id)
BF305795 muscle, rhabdomyosarcoma .e 437 to 1142 1 to 699       699/867
(80 %)
18 diff
(98.0 %id)
BF688802 eye, normal pigmented retinal epithelium .e 467 to 1028 1 to 570       570/593
(96 %)
21 diff
(96.5 %id)
AA210860 germinal center B cell .e 472 to 934 1 to 464       464/464
(100 %)
6 diff
(98.8 %id)
BF803186 colon_ins .e 478 to 912 434 to 1     Submitted on the opposite strand 434/434
(100 %)
7 diff
(98.4 %id)
BF955509 nervous_normal .e 478 to 595 127 to 9       119/127
(93 %)
0 diff
(100 %id)
DA823332 pericardium .e 487 to 1048 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN368445 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 498 to 1134 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
CX164828 human embryonic stem cells differentiated toan early endodermal cell type .e 507 to 977 9 to 480       472/480
(98 %)
11 diff
(97.8 %id)
H14682 whole brain .e 511 to 993 1 to 487       487/489
(99 %)
23 diff
(95.3 %id)
AA325907 brain, cerebellum .e 512 to 839 1 to 328       328/328
(100 %)
3 diff
(99.1 %id)
BG259976 bladder, transitional cell papilloma, cell line .e 517 to 1296 1 to 778       778/817
(95 %)
19 diff
(97.7 %id)
BE779753 eye, retinoblastoma .e 520 to 1236 1 to 719       719/950
(75 %)
13 diff
(98.7 %id)
DB123356 thymus .e 521 to 1056 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
BE297912 muscle, rhabdomyosarcoma .e 534 to 1116 28 to 616       589/624
(94 %)
18 diff
(97.2 %id)
CX757052 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 537 to 1277 1 to 735     Submitted on the opposite strand 735/803
(91 %)
68 diff
(91.6 %id)
AA323759 brain, cerebellum .e 541 to 882 1 to 343       343/343
(100 %)
1 diff
(99.8 %id)
BF304147 muscle, rhabdomyosarcoma .e 546 to 1279 1 to 744       564/966
(58 %)
41 diff
(95.8 %id)
BF306045 muscle, rhabdomyosarcoma .e 546 to 1330 1 to 769       769/820
(93 %)
24 diff
(97.1 %id)
BG825388 muscle, rhabdomyosarcoma .e 546 to 1417 1 to 865       865/930
(93 %)
21 diff
(97.8 %id)
AA325957 brain, cerebellum .e 565 to 802 1 to 238       238/238
(100 %)
1 diff
(99.6 %id)
BG911246 anaplastic oligodendroglioma with 1p/19qloss, brain .e 577 to 1296 1 to 719       719/719
(100 %)
4 diff
(99.5 %id)
BF882041 lung_tumor .e 587 to 975 1 to 387       387/387
(100 %)
3 diff
(99.3 %id)
BF737622 bladder_tumor .e 593 to 975 1 to 382       382/382
(100 %)
2 diff
(99.5 %id)
TI_57219541   .e 633 to 1512 29 to 907       879/907
(96 %)
28 diff
(97.0 %id)
BI752705 brain .e 634 to 1512 1 to 878       878/878
(100 %)
22 diff
(97.5 %id)
AA326001 brain, cerebellum .e 643 to 1016 1 to 379       379/381
(99 %)
8 diff
(98.0 %id)
BF203724 muscle, rhabdomyosarcoma .e 650 to 1293 1 to 638       640/913
(70 %)
25 diff
(97.3 %id)
BG826294 muscle, rhabdomyosarcoma .e 650 to 1353 1 to 711       711/849
(83 %)
25 diff
(97.1 %id)
BG829367 muscle, rhabdomyosarcoma .e 650 to 1248 1 to 599       599/600
(99 %)
2 diff
(99.7 %id)
BM772107 stomach .e 652 to 1244 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
AW955356   .e 659 to 1207 1 to 549       549/549
(100 %)
3 diff
(99.5 %id)
BQ320732 colon .e 664 to 989 68 to 393       326/393
(82 %)
6 diff
(98.5 %id)
BQ320740 colon .e 664 to 989 68 to 393       326/393
(82 %)
6 diff
(98.5 %id)
BF973942 leiomyosarcoma cell line, uterus .e 664 to 1316 1 to 664       664/1046
(63 %)
26 diff
(97.6 %id)
AU252996 neuroblastoma .e 668 to 1365 1 to 700       697/700
(99 %)
25 diff
(96.5 %id)
BM042410 melanotic melanoma, cell line, skin .e 673 to 1442 1 to 779       776/799
(97 %)
27 diff
(96.7 %id)
BX363898   .e 674 to 1776 1099 to 5       1092/1115
(97 %)
15 diff
(98.7 %id)
BU162444 melanotic melanoma, cell line, skin .e 675 to 1548 1 to 880       880/882
(99 %)
11 diff
(98.8 %id)
BU191447 melanotic melanoma, cell line, skin .e 675 to 1528 1 to 873       873/874
(99 %)
41 diff
(95.4 %id)
BQ681851 melanotic melanoma, cell line, skin .e 675 to 1535 1 to 862       862/865
(99 %)
4 diff
(99.6 %id)
BQ680900 melanotic melanoma, cell line, skin .e 675 to 1029 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BQ683985 melanotic melanoma, cell line, skin .e 675 to 1552 1 to 885       885/911
(97 %)
24 diff
(97.4 %id)
BU185503 melanotic melanoma, cell line, skin .e 675 to 1528 1 to 857       857/868
(98 %)
10 diff
(98.9 %id)
BG282333 melanotic melanoma, skin .e 683 to 1492 1 to 810       810/811
(99 %)
48 diff
(94.1 %id)
BG280785 melanotic melanoma, skin .e 684 to 1540 1 to 844       844/846
(99 %)
23 diff
(97.3 %id)
BQ673693 epidermoid carcinoma, cell line, salivary gland .e 700 to 1664 1 to 969       969/976
(99 %)
29 diff
(97.1 %id)
BM564652 duodenal adenocarcinoma, cell line, small intestine .e 701 to 1330 29 to 667       639/1157
(55 %)
30 diff
(97.5 %id)
BE728854 melanotic melanoma, skin .e 704 to 1436 1 to 723       723/964
(75 %)
15 diff
(98.5 %id)
BF125859 melanotic melanoma, skin .e 704 to 1419 1 to 705       705/882
(79 %)
17 diff
(98.1 %id)
BQ278650 adenocarcinoma, cell line, breast .e 713 to 1559 24 to 880       857/1061
(80 %)
24 diff
(97.8 %id)
BU539117 adenocarcinoma, cell line, breast .e 713 to 1585 22 to 902       881/976
(90 %)
26 diff
(97.4 %id)
BU857132 adenocarcinoma, cell line, breast .e 713 to 1561 1 to 858       858/952
(90 %)
13 diff
(98.7 %id)
BU857706 adenocarcinoma, cell line, breast .e 713 to 1528 1 to 820       820/870
(94 %)
9 diff
(99.0 %id)
BM543762 ovary (pool of 3) .e 724 to 1548 1 to 829       829/1106
(74 %)
30 diff
(97.3 %id)
BF930254 nervous_tumor .e 747 to 1258 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
CA392376 eye, RPE/choroid .e 749 to 1425 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
AA190436   .e 757 to 1028 1 to 276       276/306
(90 %)
9 diff
(97.1 %id)
TI_154185809   .e 757 to 1359 111 to 823       564/918
(61 %)
16 diff
(98.3 %id)
BG990044 head_neck .e 815 to 1066 253 to 3       251/253
(99 %)
5 diff
(98.1 %id)
BF377863 testis_normal .e 819 to 1232 1 to 417       416/417
(99 %)
24 diff
(94.3 %id)
TI_154139337   .e 821 to 1461 79 to 718       642/719
(89 %)
23 diff
(96.9 %id)
BU839512 hepatocellular carcinoma, cell line, Liver .e 822 to 1606 10 to 805       799/988
(80 %)
23 diff
(97.7 %id)
BQ643871 hepatocellular carcinoma, cell line, Liver .e 824 to 1680 1 to 872       872/890
(97 %)
19 diff
(97.9 %id)
BQ919091 carcinoma, cell line, Prostate .e 828 to 1598 41 to 825       785/989
(79 %)
38 diff
(96.2 %id)
BM465042 lymph, lymphoma, cell line .e 839 to 1709 1 to 880       877/1098
(79 %)
44 diff
(96.0 %id)
BQ344927 nervous_tumor .e 873 to 1141 1 to 269       269/270
(99 %)
6 diff
(97.8 %id)
BQ367981 placenta_normal .e 911 to 1241 332 to 2       328/332
(98 %)
1 diff
(99.7 %id)
BG473465 eye, retinoblastoma .e 929 to 1719 1 to 794       794/915
(86 %)
47 diff
(94.9 %id)
BE733265 choriocarcinoma, placenta .e 941 to 1753 1 to 802       799/904
(88 %)
17 diff
(98.2 %id)
BE769905 prostate_tumor .e 943 to 1300 362 to 3       357/362
(98 %)
16 diff
(95.6 %id)
BI911115 leukocyte .e 1033 to 1643 1 to 619       619/661
(93 %)
24 diff
(96.4 %id)
TI_57235564   .e 1033 to 1643 29 to 647       619/689
(89 %)
22 diff
(96.9 %id)
BQ961910 epithelioid carcinoma cell line, Pancreas .e 1047 to 1978 4 to 958       965/967
(99 %)
74 diff
(92.4 %id)
BI013084 lung_tumor .e 1051 to 1415 375 to 13       360/375
(96 %)
0 diff
(100 %id)
BI481520 Native Retinal Pigment Epithelium sheets, retina .e 1051 to 1455 24 to 439       418/451
(92 %)
30 diff
(93.4 %id)
BI481527 Native Retinal Pigment Epithelium sheets, retina .e 1051 to 1628 23 to 610       588/610
(96 %)
19 diff
(96.9 %id)
AW884142 ovary .e 1059 to 1395 17 to 355       339/361
(93 %)
12 diff
(96.7 %id)
BF905355 marrow .e 1065 to 1612 20 to 562       543/562
(96 %)
12 diff
(97.9 %id)
BQ375098 testis_normal .e 1068 to 1383 1 to 318       315/318
(99 %)
20 diff
(93.8 %id)
BF337112 brain, glioblastoma with EGFR amplification .e 1076 to 1871 1 to 790       790/811
(97 %)
29 diff
(96.5 %id)
CV378204 lung_tumor .e 1107 to 1415 42 to 350       309/359
(86 %)
12 diff
(96.7 %id)
BF947365 nervous_normal .e 1112 to 1450 393 to 53       338/426
(79 %)
0 diff
(100 %id)
BF931308 nervous_tumor .e 1115 to 1372 259 to 2     Submitted on the opposite strand 255/259
(98 %)
1 diff
(99.7 %id)
BF303700 muscle, rhabdomyosarcoma .e 1116 to 1888 1 to 753       753/937
(80 %)
31 diff
(96.7 %id)
BF304842 muscle, rhabdomyosarcoma .e 1116 to 1765 1 to 641       641/958
(66 %)
24 diff
(97.5 %id)
BF304520 muscle, rhabdomyosarcoma .e 1116 to 1833 1 to 706       708/806
(87 %)
25 diff
(96.9 %id)
BF310871 brain, neuroblastoma .e 1116 to 1846 1 to 718       718/719
(99 %)
29 diff
(96.0 %id)
BF310896 brain, neuroblastoma .e 1116 to 1748 1 to 631       633/876
(72 %)
16 diff
(98.2 %id)
CA424531 cell lines, Chondrosarcoma .e 1121 to 1796 695 to 19   AAA   677/677
(100 %)
1 diff
(99.9 %id)
CA424655 cell lines, Chondrosarcoma .e 1121 to 1798 696 to 17   AAA   680/680
(100 %)
2 diff
(99.8 %id)
BQ329586 lung_normal .e 1148 to 1312 1 to 168       168/168
(100 %)
11 diff
(93.5 %id)
CU444954 epidermis .e 1151 to 1513 13 to 375       363/389
(93 %)
1 diff
(99.8 %id)
BF360672 ovary .e 1156 to 1476 324 to 4       321/324
(99 %)
0 diff
(100 %id)
BI222821 cervical carcinoma cell line, cervix .e 1162 to 1498 1 to 339       339/676
(50 %)
5 diff
(99.3 %id)
H58575 liver and spleen .e 1163 to 1383 1 to 221       221/229
(96 %)
2 diff
(99.2 %id)
AW388475 stomach .e 1189 to 1456 281 to 15       267/281
(95 %)
0 diff
(100 %id)
AA299925 uterus .e 1192 to 1474 1 to 283       283/283
(100 %)
2 diff
(99.3 %id)
CN368451 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 1209 to 1893 20 to 704   tiling clone,   685/704
(97 %)
6 diff
(99.2 %id)
BM852876 Ascites, stomach .e 1227 to 1485 1 to 259       259/259
(100 %)
3 diff
(98.9 %id)
TI_157594407   .e 1228 to 1798 659 to 78   AAA   582/583
(99 %)
50 diff
(91.5 %id)
BM714234 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1237 to 1782 1 to 546   fully sequenced,   546/546
(100 %)
0 diff
(100 %id)
BI015019 lung_tumor .e 1278 to 1447 183 to 13       171/183
(93 %)
0 diff
(100 %id)
BG332301 large cell carcinoma, lung .e 1279 to 1993 1 to 703       703/801
(87 %)
24 diff
(97.1 %id)
BF750575 breast_normal .e 1313 to 1686 481 to 108     Submitted on the opposite strand 374/481
(77 %)
0 diff
(100 %id)
BM931072 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1329 to 1799 25 to 495   AAA   471/495
(95 %)
5 diff
(99.0 %id)
TI_227715549   .e 1336 to 2225 968 to 88   AAA   881/1022
(86 %)
11 diff
(99.0 %id)
AI609388 normal gingiva (cell line from immortalizedkeratinocytes) .e 1356 to 1797 442 to 1       442/443
(99 %)
1 diff
(99.8 %id)
AI204450   .e 1358 to 1797 442 to 3       440/442
(99 %)
0 diff
(100 %id)
R43963 whole brain .e 1376 to 1798 434 to 11   AAA   424/424
(100 %)
1 diff
(99.8 %id)
BQ670449 epidermoid carcinoma, cell line, salivary gland .e 1381 to 1812 1 to 432   AAA   432/432
(100 %)
0 diff
(100 %id)
BU601259 mixed (pool of 40 RNAs) .e 1389 to 2129 1 to 750       750/821
(91 %)
23 diff
(97.2 %id)
TI_149303178   .e 1392 to 2229 911 to 79   AAA   833/997
(83 %)
14 diff
(98.6 %id)
BM987824 mixed .e 1420 to 1799 398 to 19   AAA   380/380
(100 %)
2 diff
(99.5 %id)
TI_154038925   .e 1434 to 2229 859 to 67   AAA   793/797
(99 %)
8 diff
(99.0 %id)
TI_154101397   .e 1440 to 2229 874 to 91   AAA   784/805
(97 %)
18 diff
(97.8 %id)
BM042819 melanotic melanoma, cell line, skin .e 1446 to 2166 750 to 9       742/750
(98 %)
0 diff
(100 %id)
TI_149287728   .e 1453 to 2225 830 to 60   AAA   771/996
(77 %)
9 diff
(99.1 %id)
AI923497 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1462 to 1801 340 to 1       340/340
(100 %)
1 diff
(99.8 %id)
AW075933 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .e 1475 to 1798 324 to 1       324/324
(100 %)
7 diff
(97.9 %id)
BE963619 eye, retinoblastoma .e 1479 to 2212 792 to 30   AAA   763/1120
(68 %)
76 diff
(93.3 %id)
CD366677 Alveolar Macrophage, lung .e 1494 to 2225 747 to 19   AAA   729/729
(100 %)
3 diff
(99.6 %id)
BU743033 eye, fetal eye .e 1498 to 2225 739 to 19   AAA   721/721
(100 %)
8 diff
(98.9 %id)
BM981232 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 1515 to 2229 731 to 19   AAA   713/713
(100 %)
2 diff
(99.8 %id)
CN368447 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1524 to 1724 1 to 203       203/203
(100 %)
4 diff
(98.1 %id)
AA768029 germinal center B cell .e 1526 to 1819 306 to 13   AAA   294/303
(97 %)
10 diff
(96.7 %id)
AW294299   .e 1526 to 1804 296 to 18   AAA   279/280
(99 %)
0 diff
(100 %id)
AI766770 2 pooled tumors (clear cell type), Kidney .e 1527 to 1797 273 to 3       271/274
(98 %)
0 diff
(100 %id)
AA736511 germinal center B cell .e 1530 to 1819 302 to 13   AAA   290/290
(100 %)
0 diff
(100 %id)
CB529603 Aveolar Macrophage, lung .e 1531 to 2225 713 to 19   AAA   695/695
(100 %)
4 diff
(99.5 %id)
BU681125 lung .e 1543 to 2225 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
BE091181 breast .e 1551 to 1834 37 to 319       283/323
(87 %)
4 diff
(98.8 %id)
CK904403 Islets of Langerhans, Pancreas .e 1554 to 2089 1 to 536       536/536
(100 %)
3 diff
(99.5 %id)
BM023393 Islets of Langerhans, Pancreas .e 1571 to 2088 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
BQ052143 blood, natural killer cells, cell line .e 1571 to 2224 1 to 654       654/680
(96 %)
1 diff
(99.9 %id)
BF892066 marrow .e 1573 to 1948 1 to 376       376/376
(100 %)
0 diff
(100 %id)
BM806347 melanotic melanoma, skin .e 1581 to 2229 1 to 649   AAA   649/649
(100 %)
0 diff
(100 %id)
CB528689 Aveolar Macrophage, lung .e 1582 to 2225 663 to 19   AAA   645/645
(100 %)
1 diff
(99.9 %id)
CN368444 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1600 to 2223 1 to 624       624/628
(99 %)
6 diff
(99.1 %id)
BQ326561 colon_normal .e 1604 to 1731 127 to 1       127/127
(100 %)
2 diff
(98.5 %id)
BM768919 stomach .e 1612 to 1796 1 to 185   AAA   185/185
(100 %)
0 diff
(100 %id)
BG425508 Kidney, renal cell adenocarcinoma .e 1627 to 2226 1 to 602       602/1037
(58 %)
9 diff
(99.2 %id)
BU623872 cell lines, Enchondroma .e 1637 to 2225 607 to 19   AAA   589/589
(100 %)
0 diff
(100 %id)
BM720303 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1645 to 2181 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BQ003188 Chondrosarcoma, Left Pelvis .e 1651 to 2223 591 to 19   AAA   573/573
(100 %)
0 diff
(100 %id)
CA444976 lung, Metastatic Chondrosarcoma .e 1651 to 2229 595 to 19   AAA   577/577
(100 %)
3 diff
(99.5 %id)
AA573803 colon, tumor .e 1658 to 2196 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
BI257617 cervical carcinoma cell line, cervix .e 1659 to 2225 1 to 566   AAA   566/566
(100 %)
1 diff
(99.9 %id)
EC562517 Prostate .e 1676 to 1802 125 to 3       123/134
(91 %)
0 diff
(100 %id)
CA412637 Chondrosarcoma Grade II, Left Pelvis .e 1682 to 2225 563 to 19   AAA   545/545
(100 %)
1 diff
(99.9 %id)
CB243128 Human Lung Epithelial cells, lung .e 1699 to 2408 727 to 19   tiling clone, AAA   709/710
(99 %)
1 diff
(99.9 %id)
BQ021476 lung, Metastatic Chondrosarcoma .e 1702 to 2225 540 to 19   AAA   522/528
(98 %)
6 diff
(98.9 %id)
CA426657 cell lines, Chondrosarcoma .e 1704 to 2225 540 to 19   AAA   522/522
(100 %)
0 diff
(100 %id)
AA534412 colon .e 1705 to 2225 520 to 2       519/522
(99 %)
0 diff
(100 %id)
CA441866 Chondrosarcoma, Left Pubic Bone .e 1718 to 2229 530 to 19   AAA   512/512
(100 %)
0 diff
(100 %id)
AI673040 thymus, pooled .e 1731 to 2225 498 to 4       495/498
(99 %)
0 diff
(100 %id)
AI798620 Prostate .e 1740 to 2225 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AI952808 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1740 to 2225 503 to 18   AAA   486/486
(100 %)
5 diff
(99.0 %id)
AI743323 pooled .e 1741 to 2223 488 to 8       481/488
(98 %)
0 diff
(100 %id)
AI745610 Prostate .e 1749 to 2225 483 to 7       477/483
(98 %)
0 diff
(100 %id)
AW167112 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1749 to 2225 492 to 16   AAA   477/477
(100 %)
3 diff
(99.4 %id)
BM676614 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1752 to 2225 489 to 19   fully sequenced, AAA   471/471
(100 %)
0 diff
(100 %id)
AA219657 brain, neuroepithelial cells .e 1753 to 2225 474 to 3       472/480
(98 %)
0 diff
(100 %id)
AI751485 Bone, Hip .e 1761 to 2225 473 to 9       465/473
(98 %)
0 diff
(100 %id)
AA609752   .e 1767 to 2225 461 to 4       458/461
(99 %)
0 diff
(100 %id)
BG168762 hypernephroma, cell line, Kidney .e 1767 to 2224 30 to 490       461/508
(90 %)
11 diff
(97.9 %id)
BG168700 hypernephroma, cell line, Kidney .e 1767 to 2224 30 to 486   AAA   457/486
(94 %)
6 diff
(98.8 %id)
AI968621 pooled germ cell tumors .e 1778 to 2225 448 to 1       448/448
(100 %)
2 diff
(99.6 %id)
AA641408 epithelium (cell line), Prostate .e 1779 to 2143 365 to 3       363/365
(99 %)
0 diff
(100 %id)
AI302063 carcinoid, lung .e 1781 to 2164 1 to 384     Submitted on the opposite strand 384/384
(100 %)
0 diff
(100 %id)
AA694504   .e 1785 to 2194 410 to 1       410/410
(100 %)
7 diff
(98.3 %id)
BG954903 colon .e 1785 to 2099 330 to 13       318/330
(96 %)
0 diff
(100 %id)
DB546246 hippocampus .e 1787 to 2227 1 to 441     Submitted on the opposite strand 441/442
(99 %)
2 diff
(99.6 %id)
CB045771 colon, juvenile granulosa tumor .e 1787 to 2225 477 to 39   AAA   439/439
(100 %)
12 diff
(97.3 %id)
AA932833 pooled germ cell tumors .e 1791 to 2225 438 to 4       435/438
(99 %)
0 diff
(100 %id)
DB529567 hippocampus .e 1792 to 2225 1 to 437     Submitted on the opposite strand 437/437
(100 %)
21 diff
(95.2 %id)
AW016038   .e 1795 to 2225 448 to 18   AAA   431/431
(100 %)
0 diff
(100 %id)
CA435457 lung, Metastatic Chondrosarcoma .e 1811 to 2224 432 to 19   AAA   414/414
(100 %)
2 diff
(99.6 %id)
AA572883   .e 1815 to 2223 424 to 17   AAA   408/409
(99 %)
2 diff
(99.6 %id)
DB559166 hypothalamus .e 1816 to 2227 1 to 410     Submitted on the opposite strand 410/411
(99 %)
11 diff
(97.4 %id)
CB050894 Prostate .e 1817 to 2223 13 to 419   fully sequenced, AAA   407/419
(97 %)
6 diff
(98.6 %id)
AW474411 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1828 to 2224 407 to 11   AAA   397/397
(100 %)
0 diff
(100 %id)
AI251430 brain, tumor, 5 pooled (see description) .e 1830 to 2225 397 to 2       396/397
(99 %)
0 diff
(100 %id)
BM726830 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 1843 to 2220 1 to 378       378/378
(100 %)
0 diff
(100 %id)
AI497949 anaplastic oligodendroglioma, brain .e 1844 to 2225 382 to 1       382/382
(100 %)
0 diff
(100 %id)
AI424327 Prostate .e 1850 to 2223 383 to 10       374/383
(97 %)
0 diff
(100 %id)
BE857730 Prostate .e 1850 to 2223 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BE859080 Prostate .e 1850 to 2223 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AI079983 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1858 to 2225 371 to 4       368/371
(99 %)
0 diff
(100 %id)
CB050893 Prostate .e 1859 to 2223 389 to 25   fully sequenced, AAA   365/365
(100 %)
1 diff
(99.8 %id)
AA653688 normal prostate, Prostate .e 1860 to 2224 363 to 1       363/363
(100 %)
2 diff
(99.5 %id)
AI952926 pooled germ cell tumors .e 1864 to 2230 371 to 5       367/371
(98 %)
0 diff
(100 %id)
AI654217 pooled germ cell tumors .e 1868 to 2225 358 to 1       358/358
(100 %)
2 diff
(99.5 %id)
AW339581 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .e 1889 to 2223 335 to 1       335/335
(100 %)
0 diff
(100 %id)
EC465392 Prostate .e 1909 to 2013 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
EC552707 Prostate .e 1909 to 2009 1 to 101       101/103
(98 %)
3 diff
(97.1 %id)
EC581944 Prostate .e 1910 to 2009 1 to 98       98/100
(98 %)
3 diff
(97.0 %id)
EC450741 Prostate .e 1911 to 2012 1 to 99       99/99
(100 %)
5 diff
(95.0 %id)
EC465461 Prostate .e 1911 to 2013 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC480221 Prostate .e 1911 to 2013 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC510060 Prostate .e 1911 to 2013 1 to 105       105/105
(100 %)
2 diff
(98.1 %id)
EC538537 Prostate .e 1911 to 2012 1 to 102       102/102
(100 %)
0 diff
(100 %id)
EC552681 Prostate .e 1911 to 2012 1 to 102       102/102
(100 %)
0 diff
(100 %id)
EC552782 Prostate .e 1911 to 2009 1 to 99       99/101
(98 %)
1 diff
(99.1 %id)
EC581918 Prostate .e 1911 to 2009 1 to 99       99/101
(98 %)
1 diff
(99.1 %id)
EC582043 Prostate .e 1911 to 2013 1 to 103       103/103
(100 %)
0 diff
(100 %id)
AA228882   .e 1911 to 2223 332 to 22   AAA   311/311
(100 %)
2 diff
(99.4 %id)
AW769963 lymph node, lymphoma, follicular mixed small and largecell .e 1916 to 2225 313 to 4       310/313
(99 %)
0 diff
(100 %id)
AA210730 germinal center B cell .e 1930 to 2223 300 to 7       294/300
(98 %)
0 diff
(100 %id)
AI380222 B-cell, chronic lymphotic leukemia .e 1933 to 2225 297 to 5       293/297
(98 %)
0 diff
(100 %id)
GD160812   .e 1937 to 2226 1 to 290   AAA   290/290
(100 %)
11 diff
(96.3 %id)
BP425955 small intestine .e 1938 to 2118 1 to 181     Submitted on the opposite strand 181/181
(100 %)
0 diff
(100 %id)
DB556379 hypothalamus .e 1963 to 2227 1 to 266     Submitted on the opposite strand 266/267
(99 %)
7 diff
(97.4 %id)
AI474366 Prostate .e 1969 to 2225 261 to 2       260/261
(99 %)
0 diff
(100 %id)
CV570298 cornea, eye .e 1977 to 2226 1 to 250   AAA   250/250
(100 %)
0 diff
(100 %id)
BU623985 cell lines, Enchondroma .e 1980 to 2225 264 to 19   AAA   246/246
(100 %)
3 diff
(98.8 %id)
AA634068   .e 1982 to 2408 440 to 15   AAA   426/426
(100 %)
1 diff
(99.8 %id)
AA610823 thyroid .e 1982 to 2223 263 to 23   AAA   241/241
(100 %)
1 diff
(99.6 %id)
AI766015 Kidney .e 1983 to 2230 248 to 1       248/248
(100 %)
0 diff
(100 %id)
AI825266 pooled germ cell tumors .e 1991 to 2225 235 to 1       235/243
(96 %)
1 diff
(99.6 %id)
AI801722 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 2004 to 2223 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AI696036 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
AI825530 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
AI652963 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
2 diff
(99.1 %id)
AI991582 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
AI989516 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
BE671943 pooled germ cell tumors .e 2024 to 2225 202 to 1       202/202
(100 %)
1 diff
(99.6 %id)
AI990900 pooled germ cell tumors .e 2055 to 2225 171 to 1       171/171
(100 %)
1 diff
(99.5 %id)
EC523520 Prostate .e 2096 to 2191 1 to 96       96/96
(100 %)
0 diff
(100 %id)
BI258222 cervical carcinoma cell line, cervix .e 2188 to 2408 1 to 219   AAA   219/219
(100 %)
2 diff
(99.1 %id)
AI143660 anaplastic oligodendroglioma, brain .e 2232 to 2409 196 to 19   AAA   178/178
(100 %)
4 diff
(97.8 %id)
TI_57242838   .f 1 to 774 26 to 799 V2M tiling clone,   774/800
(96 %)
9 diff
(98.9 %id)
BI914208 brain .f 6 to 774 1 to 769   tiling clone,   769/770
(99 %)
3 diff
(99.7 %id)
BF894318 marrow .f 693 to 1197 509 to 5   tiling clone, Submitted on the opposite strand 505/509
(99 %)
0 diff
(100 %id)
DA811765 ovary, tumor tissue .g 1 to 839 2 to 850 exact tiling clone, capped   849/866
(98 %)
17 diff
(98.1 %id)
AU154790 ovary, tumor tissue .g 1111 to 1709 599 to 1   tiling clone,   599/599
(100 %)
17 diff
(97.2 %id)
CN368449 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h-u 1 to 615 1 to 614 I2R K4R V5S L6W G7E ... tiling clone,   614/614
(100 %)
5 diff
(99.2 %id)
BM691370 eye, RPE and Choroid .i-u 1 to 293 2 to 294   tiling clone, fully sequenced,   293/294
(99 %)
5 diff
(98.3 %id)
AW028853 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .i-u 253 to 725 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
BM662398 eye, RPE and Choroid .i-u 263 to 739 477 to 1   tiling clone, fully sequenced,   477/477
(100 %)
0 diff
(100 %id)
AJ973487 foetal lung .i-u 278 to 555 1 to 278       278/278
(100 %)
0 diff
(100 %id)
AJ973488 foetal lung .i-u 278 to 555 278 to 1     Submitted on the opposite strand 278/283
(98 %)
0 diff
(100 %id)
BP385196 pancreatic islet .i-u 494 to 725 1 to 232     Submitted on the opposite strand 232/232
(100 %)
0 diff
(100 %id)
BE304407 adenocarcinoma cell line, colon .j 1 to 614 1 to 614 exact tiling clone,   614/614
(100 %)
1 diff
(99.9 %id)
BF875134 lung_tumor .j 47 to 437 390 to 1     Submitted on the opposite strand 390/390
(100 %)
1 diff
(99.8 %id)
BE294129 muscle, rhabdomyosarcoma .j 134 to 636 1 to 503       503/505
(99 %)
6 diff
(98.9 %id)
BQ774456 Chondrosarcoma Grade II, Left Pelvis .j 145 to 803 680 to 19   AAA   662/662
(100 %)
5 diff
(99.3 %id)
BM040927 Kidney, Wilms' tumor, cell line .j 161 to 774 1 to 615       615/713
(86 %)
13 diff
(98.2 %id)
TI_151786431   .j 162 to 738 107 to 691       585/647
(90 %)
12 diff
(98.2 %id)
BU535580 adenocarcinoma, cell line, breast .j 171 to 797 1 to 627   AAA   627/627
(100 %)
0 diff
(100 %id)
AW388521 stomach .j 188 to 586 400 to 4       397/400
(99 %)
0 diff
(100 %id)
BG034939 adenocarcinoma, cell line, Liver .j 197 to 819 1 to 630       630/638
(98 %)
21 diff
(96.8 %id)
BE548273 cervical carcinoma cell line, cervix .j 202 to 800 1 to 599       599/599
(100 %)
17 diff
(97.2 %id)
CN368450 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 208 to 801 12 to 606       595/608
(97 %)
2 diff
(99.7 %id)
CN368452 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 208 to 761 20 to 573       554/573
(96 %)
6 diff
(99.0 %id)
T99909 liver and spleen .j 216 to 534 1 to 327   fully sequenced,   327/327
(100 %)
10 diff
(97.0 %id)
BX090809 liver and spleen .j 217 to 829 1 to 615   tiling clone, AAA   615/615
(100 %)
3 diff
(99.6 %id)
CN368454 embryonic stem cells, DMSO-treated H9 cellline .j 229 to 581 1 to 353       353/353
(100 %)
1 diff
(99.8 %id)
BM701530 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 257 to 692 1 to 434       434/434
(100 %)
6 diff
(98.7 %id)
T99804 liver and spleen .j 519 to 826 319 to 6   fully sequenced,   314/319
(98 %)
0 diff
(100 %id)
BF349779 head_neck .k 1 to 412 1 to 410 I74T H75R     410/420
(97 %)
15 diff
(96.5 %id)
BE145971 head_neck .k 11 to 405 9 to 403   tiling clone,   395/419
(94 %)
7 diff
(98.4 %id)
BE146046 head_neck .k 11 to 412 8 to 409 E59K I74T H75R     402/419
(95 %)
12 diff
(97.2 %id)
BE146148 head_neck .k 11 to 412 412 to 11 I74T H75R   Submitted on the opposite strand 402/413
(97 %)
2 diff
(99.6 %id)
AA421129   .k 12 to 204 1 to 194   tiling clone,   194/194
(100 %)
5 diff
(97.5 %id)
AA382152   .k 18 to 192 1 to 175       175/175
(100 %)
2 diff
(98.9 %id)
BE146316 head_neck .k 28 to 412 19 to 407 F28L T29P T30P Y31T I32L ...     389/417
(93 %)
12 diff
(97.2 %id)
TI_57174295   .l 1 to 728 21 to 771   tiling clone,   751/1094
(68 %)
23 diff
(97.9 %id)
BI826885 brain, medulla .l 9 to 728 1 to 743   tiling clone,   741/1066
(69 %)
39 diff
(96.4 %id)
BF511297   .l 625 to 1214 591 to 1 N22Y tiling clone,   591/591
(100 %)
2 diff
(99.7 %id)
DW429911 Liver .l 633 to 1016 11 to 394   tiling clone,   384/394
(97 %)
9 diff
(97.8 %id)
DW442679 Liver .l 633 to 855 11 to 233       223/233
(95 %)
6 diff
(97.5 %id)
DW426352 Liver .m 1 to 268 13 to 280 K33R tiling clone,   268/282
(95 %)
9 diff
(96.9 %id)
DW438208 Liver .m 1 to 233 13 to 246 K33R L53T F54L R55P A56G ... tiling clone,   234/246
(95 %)
10 diff
(96.0 %id)
DW467624 Liver .n 1 to 327 19 to 345 G57S tiling clone,   334/345
(96 %)
7 diff
(98.0 %id)
AJ973485 bone marrow .o 1 to 135 1 to 135 exact tiling clone,   135/135
(100 %)
0 diff
(100 %id)
AJ973486 bone marrow .o 1 to 135 135 to 1 exact   Submitted on the opposite strand 135/135
(100 %)
0 diff
(100 %id)
AW836851 leiomios Gene OTUD5, variant not shown         This clone was ignored    
AW836945 leiomios Gene OTUD5, variant not shown         This clone was ignored    
AW836960 leiomios Gene OTUD5, variant not shown         This clone was ignored    
BC028225 Brain, fetal, whole pooled Gene OTUD5, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BC098440 Skin, melanotic melanoma, high MDR. Gene OTUD5, variant not shown       AAA This clone was ignored    
CN368456 embryonic stem cells, DMSO-treated H9 cellline Gene OTUD5, variant not shown         Suspected internal deletion, this clone was ignored    
CU455584 epidermis Gene OTUD5, variant not shown         This clone was ignored    
AW450098   Gene OTUD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AW450099   Gene OTUD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AW451140   Gene OTUD5, variant not shown         This clone was ignored    
BQ028146 mixed Gene OTUD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG481733 choriocarcinoma, placenta Gene OTUD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BG760747 melanotic melanoma, high MDR (cell line), skin Gene OTUD5, variant not shown         This clone was ignored    
BG750585 eye, normal pigmented retinal epithelium Gene OTUD5, variant not shown         This clone was ignored    
BQ009623 Chondrosarcoma, Left Pubic Bone Gene OTUD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AU155334 ovary, tumor tissue Gene OTUD5, variant not shown         Suspected internal deletion, this clone was ignored    
DA812517 ovary, tumor tissue Gene OTUD5, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j, .k, .l, .m, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI